- [PRESSWIRE] YORBA LINDA, Calif., April 9, 2019 — Breaking from the traditional format of Liveyon’s live ‘Pure-Cast,’ Liveyon founder and CEO sat down with his mother, Lois Christianson, in a heartfelt conversation on how stem cell treatment saved her life after a horrifying injury.
- [PRESSWIRE] MOUNTAIN VIEW, Calif., April 1, 2019 — GetInsured, a leading provider of health insurance marketplace platforms, has abolished $1,856,771.28 of residents’ medical debt in its home state of California, to help alleviate some of the severe financial hardship caused by unpaid and un-payable medical bills.
- [PRESSWIRE] PEORIA, Ill., March 27, 2019 — A new collaboration between Peoria, Illinois-based OSF HealthCare and Redox, based in Madison, Wisconsin, will allow the health system to effectively integrate pilot programs and deploy digital health solutions to improve health for OSF HealthCare communities. Redox will serve as an application layer connecting third-party technology solutions to the OSF HealthCare clinical systems.
- [PRESSWIRE] SAN DIEGO, March 27, 2019 — Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced three presentations of updated clinical and preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2019, to be held March 29-April 3 in Atlanta and the 2019 American Association of Neurological Surgeons (AANS) Annual Meeting, to be held April 13-17 in San Diego.
- [PRESSWIRE] NEW YORK and BASEL, Switzerland, March 19, 2019 — Today Roivant subsidiary Urovant Sciences announced topline results from its Phase 3 EMPOWUR trial of vibegron in patients with overactive bladder. Vibegron achieved statistically significant improvements over placebo on both co-primary endpoints of the study as well as all seven key secondary endpoints. Over 30 million Americans over the age of 40 suffer from overactive bladder.
- [PRESSWIRE] Parma – 05 March, 2019 — “Kidney health for everyone everywhere” – ERA-EDTA has helped to put this motto into practice by offering support for young nephrologists living in disadvantage areas.
- [PRESSWIRE] Parma – 05 March, 2019 — 850 million people worldwide are affected by kidney disease [1] – a worrying figure, and one that continues to rise. Prevention of chronic kidney disease is therefore more important than ever, as Professor Carmine Zoccali (Reggio Calabria, Italy), President of the ERA-EDTA, emphasizes on the occasion of World Kidney Day on March 14, 2019.
- [PRESSWIRE] Brussels, 28 February 2019 – Today, Digestive Cancers Europe launched a campaign to promote colorectal cancer screening at the occasion of the start of European Colon Cancer Awareness Month (ECCAM). The event took place at the European Parliament and was hosted by MEP Lieve Wierinck (ALDE).
- [PRESSWIRE] Parma – 26 February, 2019 — A new analysis of the ERA-EDTA Registry [1] reveals a striking gender difference in the incidence and prevalence of end-stage renal disease.
- [PRESSWIRE] – Parma – February 18, 2019 — Results bear one clear key message: good treatment is important! Patients in whom the acidosis had been properly controlled by adequate treatment had better growth and better kidney function than those with inadequate treatment.
- [PRESSWIRE] Parma – January 31, 2019 — 850 million people worldwide are affected by kidney disease. This worrying figure was published last June by the three leading nephrology societies (ASN, ISN and ERA-EDTA) [1] – and it continues to rise at an alarming rate.
- [PRESSWIRE] Germany – 21 December, 2018 — A study published in JAMA [1] showed: Nephrologists treat the most complex patients. As ERA-EDTA president Professor Carmine Zoccali explains, kidney patients are highly vulnerable and need special care, but nephrology is a neglected discipline in many European healthcare systems. According to the “European Renal Association – European Dialysis and Transplant Association” (ERA-EDTA) it is time for a paradigm shift. There is a need for a better financial funding of nephrology – as well as more efforts to raise awareness for kidney disease in the population.
- [PRESSWIRE] Germany – 17 December, 2018 — The EKHA project “Improving Organ Donation and Transplantation in the EU” will be launched on the European Commission’s Health Policy Platform in 2019, an interactive tool to boost discussions about public health concerns and to share knowledge and best practices.
- [PRESSWIRE] Weimar, Germany – 14 November, 2018 — It is well known that air pollution causes lung cancer, weakens the lung function or triggers asthma. There is also evidence that there is an association between air pollution and birth defects, immune defects or even autism.
- [PRESSWIRE] Italy – 9 November, 2018 — Cardioline S.p.A. is pleased to announce the addition of Brian Brenegan as its Chief Executive Officer.
- [PRESSWIRE] Weimar, Germany – 29 October, 2018 — The renewed interest in anti-GBM disease is spurred by the detection of autoantibodies in other forms of glomerulonephritis and has led to an exciting development in studies on pathogenesis as well as diagnosis and management. The newly published review [1] by Professor Mårten Segelmark, gives a comprehensive update on Anti-GBM disease subgroups, pathogenesis and therapies. “A must-read for all nephrologist”, explains Professor Denis Fouque, editor-in-chief of Nephrology Dialysis and Transplantation (NDT), the journal in which the review was published.
- [PRESSWIRE] Paris – September 12, 2018 — Tattooing has gained tremendous popularity in Western countries. In Australia, Finland France and Germany, approximately 10% of the populations have at least one tattoo [1]. The ‘tattoo craze’ is particularly strong among the young generation, in which every third or fourth person has a tattoo.
- [PRESSWIRE] Paris – September 12, 2018 — The sun is one of the most dangerous carcinogens, yet people who work outdoors are inadequately protected. Since 2014, data on the UV exposure of outdoor workers (such as farmers, road workers, seasonal harvest workers, building workers, roofers, etc.) have been collected in Germany as part of the GENESIS-UV project – with alarming results.
- [PRESSWIRE] Paris – September 12, 2018 — Psoriasis is a chronic, non-communicable skin disease characterized by bright, silvery-white scales on reddened (inflamed) patches of skin, mainly on the arms and legs, the scalp, but also on many other areas of the body, including the genitals.
- [PRESSWIRE] Paris – September 12, 2018 — HPV genital infections are the most frequent sexually transmitted infections of viral origin and definitely represent a global burden with significant oncogenic potential. HPV infection causes external genital warts, and some HPV types are strongly associated with cancer or precancerous lesions. HPV induced cancers are mostly (but not only!) those of the ano-genital region, such as cervical, anal, vulvar, penile cancer, etc., but the cancers of the mouth and/or throat are also included.
- [PRESSWIRE] Parma – 12 September, 2018 — A study, which has been published in NDT [1] today shows that caffeine consumption is associated with a lower mortality rate in CKD patients. This relationship has already been observed in the general population. Although this study shows that this association may persist if caffeine is consumed through caffeine-containing soft drinks, the president of the European Renal Nutrition Working Group, Professor Denis Fouque, recommends CKD patients not to consume these soft drinks, but to drink coffee or tea instead.
- [PRESSWIRE] Parma – 06 August, 2018 — New NDT study [1] shows that `normal´ pre-dialysis blood pressure measurement is not reliable. “Without performing extended ambulatory BP recordings (44h – 48h) we approvingly accept an error rate of about 30% in the diagnosis of hypertension in dialysis patients, a highly vulnerable patient group with a dramatically elevated cardiovascular risk. This is why EURECA-m recommends ambulatory blood pressure monitoring as gold standard for the diagnosis for hypertension in hemodialysis patient.”
- [PRESSWIRE] HUNTINGTON BEACH, Calif., Aug. 3, 2018 — Building on the company’s pioneering approach to prevention, diagnosis and treatment of mental illness and comorbid conditions, D’Amore Healthcare today announced the availability of a new program that will help organizations prevent associate fatigue and licit or illicit substance dependence.
- [PRESSWIRE] Parma – 10 July, 2018 — An Indian working group published five cases of nephrotic syndrome caused by MN with evidence of chronic mercury poisoning due to consumption of traditional Indian medicines such as Siddha and Ayurveda. The article was published in “Clinical Kidney Journal” (ckj), an official journal of the ERA-EDTA. “As long as there are no strict quality controls for substances used in traditional medicine, we have to warn our patients: Mercury poisoning can lead to MN as well as to many other severe health problems, affecting the brain, the gut and the kidneys.”
- [PRESSWIRE] Franklin, IN – 09 July, 2018 — G&H Orthodontics is a full line manufacturer of orthodontic products. G&H has supplied Orthodontists worldwide with the best products on the market for over 40 years. We are proud of the reputation that we have garnered in the industry and continue to look for ways to bring quality products to our customers. For this reason, we are excited to announce our collaboration with Premier Dental, and to offer our customers even more outstanding treatment options.
- [PRESSWIRE] ‘s-Hertogenbosch, The Netherlands – 5 July, 2018 — A total grant sum of EUR 2 million has been awarded to a multidisciplinary EUROSTARS consortium. The EUROSTARS project is titled “Treatment Response Monitoring for Cancer Immunotherapies Using Immune Repertoire Analysis” and named IMMUNOMONITOR.
- [PRESSWIRE] Parma – 29 June, 2018 — The ERA-EDTA and the Japanese Society of Nephrology (JSN) are delighted to announce continuing progress in their joint collaboration in the important field of mineral and bone disorder in chronic kidney disease (CKD-MBD). This serious condition affects most people as their kidney disease progresses.
- [PRESSWIRE] Germany – 27 June, 2018 — Kidney diseases have so far been underestimated in many respects: most people are not aware of their impaired kidney function. In general, kidney diseases are “silent diseases”, most often there are no apparent early symptoms. Many people with kidney diseases are not aware that they have been living with higher risks of cardiovascular diseases, infections, hospitalizations, and of course kidney failure which requires dialysis or transplantation.
- [PRESSWIRE] SEATTLE, June 22, 2018 — LumiThera Inc., a commercial stage medical device company focused on developing non-invasive Photobiomodulation (PBM) therapies for ocular disorders and disease, announced CE Mark Certification for the European Union (EU) for the treatment of dry age-related macular degeneration (AMD) utilizing its LT-300 Light Delivery System.
- [PRESSWIRE] Boston, MA – June 12, 2018 — Zaluvida a global life science group, announced today the formation of a Scientific Advisory Board (SAB) to inform the Human Health Research & Development department about the latest research, scientific methods, and opportunities for weight-loss management, and help further technology and product development for the company.